Fujian Wanchen Biotechnology Group Statistics

Total Valuation

Fujian Wanchen Biotechnology Group has a market cap or net worth of CNY 14.06 billion. The enterprise value is 13.61 billion.

Market Cap	14.06B
Enterprise Value	13.61B

Important Dates

The next estimated earnings date is Saturday, April 19, 2025.

Earnings Date	Apr 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Fujian Wanchen Biotechnology Group has 179.99 million shares outstanding. The number of shares has increased by 13.53% in one year.

Current Share Class	n/a
Shares Outstanding	179.99M
Shares Change (YoY)	+13.53%
Shares Change (QoQ)	+13.70%
Owned by Insiders (%)	14.65%
Owned by Institutions (%)	8.91%
Float	73.36M

Valuation Ratios

The trailing PE ratio is 235.97 and the forward PE ratio is 68.84.

PE Ratio	235.97
Forward PE	68.84
PS Ratio	0.51
PB Ratio	15.36
P/TBV Ratio	16.49
P/FCF Ratio	7.53
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.99, with an EV/FCF ratio of 7.28.

EV / Earnings	235.88
EV / Sales	0.54
EV / EBITDA	15.99
EV / EBIT	21.00
EV / FCF	7.28

Financial Position

The company has a current ratio of 1.07, with a Debt / Equity ratio of 1.31.

Current Ratio	1.07
Quick Ratio	0.52
Debt / Equity	1.31
Debt / EBITDA	1.83
Debt / FCF	0.83
Interest Coverage	12.50

Financial Efficiency

Return on equity (ROE) is 36.70% and return on invested capital (ROIC) is 18.75%.

Return on Equity (ROE)	36.70%
Return on Assets (ROA)	9.01%
Return on Capital (ROIC)	18.75%
Revenue Per Employee	5.03M
Profits Per Employee	11,604
Employee Count	4,972
Asset Turnover	5.56
Inventory Turnover	19.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +116.68% in the last 52 weeks. The beta is 0.25, so Fujian Wanchen Biotechnology Group's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	+116.68%
50-Day Moving Average	72.67
200-Day Moving Average	39.46
Relative Strength Index (RSI)	56.65
Average Volume (20 Days)	2,350,463

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Fujian Wanchen Biotechnology Group had revenue of CNY 25.01 billion and earned 57.69 million in profits. Earnings per share was 0.33.

Revenue	25.01B
Gross Profit	2.60B
Operating Income	648.15M
Pretax Income	620.90M
Net Income	57.69M
EBITDA	757.15M
EBIT	648.15M
Earnings Per Share (EPS)	0.33

Full Income Statement

Balance Sheet

The company has 2.29 billion in cash and 1.56 billion in debt, giving a net cash position of 732.90 million or 4.07 per share.

Cash & Cash Equivalents	2.29B
Total Debt	1.56B
Net Cash	732.90M
Net Cash Per Share	4.07
Equity (Book Value)	1.19B
Book Value Per Share	5.09
Working Capital	339.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.06 billion and capital expenditures -187.97 million, giving a free cash flow of 1.87 billion.

Operating Cash Flow	2.06B
Capital Expenditures	-187.97M
Free Cash Flow	1.87B
FCF Per Share	10.38

Full Cash Flow Statement

Margins

Gross margin is 10.38%, with operating and profit margins of 2.59% and 0.23%.

Gross Margin	10.38%
Operating Margin	2.59%
Pretax Margin	2.48%
Profit Margin	0.23%
EBITDA Margin	3.03%
EBIT Margin	2.59%
FCF Margin	7.47%

Dividends & Yields

Fujian Wanchen Biotechnology Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	52.36%
Buyback Yield	-13.53%
Shareholder Yield	-13.53%
Earnings Yield	0.42%
FCF Yield	13.29%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Fujian Wanchen Biotechnology Group has an Altman Z-Score of 4.87.

Altman Z-Score	4.87
Piotroski F-Score	n/a